Subscribe To
Patient with candida krusei infection in matinas biopharma’s oral mat2203 expanded access program achieves complete clinical resolution
BEDMINSTER, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on de...
October 11, 2023, 11:30 am
Matinas biopharma to present at two investment conferences in october 2023
BEDMINSTER, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on re...
September 28, 2023, 7:00 am
Matinas biopharma announces notification of nyse american continued listing deficiency
BEDMINSTER, N.J., Sept. 22, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on r...
September 22, 2023, 9:25 pm
Nano one materials successfully completes phase two of co-development project with cbmm
Nano One Materials Corp (TSX:NANO, OTC:NNOMF) said phase two of the advanced lithium-ion battery cathode materials coating co-development project wi...
May 17, 2023, 8:16 am
Matinas biopharma to present at the jmp securities life sciences conference on may 15, 2023
BEDMINSTER, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on deli...
May 11, 2023, 7:30 am
nanocrystal packaging coating market size is projected to be valued at us$ 187 million in 2023 and is expected to rise to us$ 289 million by 2033 at a cagr of 4.4% | future market insights, inc.
Europe holds a prominent position globally with an influential market share of 23.3% in 2022. In addition, the European Commission has actively promot...
May 11, 2023, 12:30 am
Matinas biopharma to provide corporate update and 2023 business outlook on january 30, 2023
Conference call and live audio webcast scheduled for Monday, January 30th at 4:30 p.m. ET BEDMINSTER, N.J., Jan. 23, 2023 (GLOBE NEWSWIRE) — Matinas...
January 23, 2023, 12:00 pm
Hc wainwright initiates coverage on this nanocrystals stock
H.C. Wainwright initiated coverage on Clene Inc (NASDAQ: CLNN) with a Buy rating and a $16 price target. Clene is focused on the development of ...
July 18, 2022, 3:15 pm